NATASHA FERRERA: Open Payments
NPI 1508265711 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 43 payments from 10 companies in 2025. Trend: 2023 $304 · 2024 $968 · 2025 $1,010
Food & beverage: $1,010
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $259 |
| ABBVIE INC. | 13 | $230 |
| Ardelyx, Inc. | 8 | $162 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Madrigal Pharmaceuticals | 4 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Teleflex LLC | 1 | $25 |
| QOL Medical, LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: TREMFYA, IBSRELA, ZENPEP, SKYRIZI, REZDIFFRA, RINVOQ, ENTYVIO, LINZESS.
Industry payments across FL — which companies pay providers there.
